Medicine and Dentistry
Cystic Fibrosis
81%
Hereditary Hemorrhagic Telangiectasia
24%
Silo-Filler's Disease
21%
Pediatrics
20%
Prevalence
18%
Pulmonary Arteriovenous Fistula
17%
Patient Registry
16%
Symptom
14%
Forced Expiratory Volume
13%
Disease
12%
Infection
12%
Prematurity
11%
Cohort Analysis
9%
Pseudomonas aeruginosa
9%
Exercise Test
9%
Asthma
9%
Patient with Cystic Fibrosis
8%
Antibiotics
8%
Lung Dysplasia
8%
Atypical Mycobacterium
7%
COVID-19
7%
Diagnosis
7%
Palivizumab
7%
Bronchoscopy
6%
Cerebral Arteriovenous Malformation
6%
Lung Function
6%
Sputum
6%
Sputum Culture
6%
Dyspnea
6%
Bronchiolitis
6%
Embolization
6%
Adolescent
6%
Screening
6%
Epistaxis
6%
Allergic Bronchopulmonary Aspergillosis
5%
Bleeding
5%
Quality of Life
5%
Body Mass Index
5%
Childbirth
5%
Fatty Acid Desaturation
5%
Hypercapnia
5%
Lung Clearance
5%
Keyphrases
Cystic Fibrosis
100%
Hereditary Hemorrhagic Telangiectasia
29%
Forced Expiratory Volume in 1 Second (FEV1)
26%
Pulmonary Arteriovenous Malformation
17%
Patient Registry
17%
Europe
11%
Epistaxis
11%
Pseudomonas Aeruginosa (P. aeruginosa)
10%
Risk Factors
9%
Propranolol
9%
Pulmonary Outcomes
9%
Pediatric
8%
Israeli
8%
Allergic Bronchopulmonary Aspergillosis
8%
Bronchopulmonary Dysplasia
8%
Cerebral Arteriovenous Malformation
8%
Lung Disease
8%
Respiratory Symptoms
7%
COVID-19
7%
Cardiopulmonary Exercise Testing
7%
Israel
7%
Mycobacterium Tuberculosis (M. tb)
7%
Palivizumab
7%
Sputum Culture
7%
Pulmonary Function Test
6%
Elexacaftor-tezacaftor-ivacaftor
6%
Face Mask
6%
Bronchoscopy
6%
Hospitalization
6%
Extremely Premature Birth
6%
Symptomatic children
6%
Asthmatic children
6%
Preconception Carrier Screening
6%
Dry Powder Inhaler
6%
Multicenter Cohort Study
6%
Lung Function
6%
Spirometry
6%
Sputum
5%
Pulmonary Function
5%
Post-infection
5%
Age at Diagnosis
5%
Clinical Characteristics
5%
